Placental growth factor testing at 19-23  weeks of gestation as a guide to subsequent care in pregnancy: A prospective observational study

CONCLUSIONS: Clinical risk factor screening has a high screen-positive rate and a poor detection of adverse outcomes. False positives cannot be reduced by PlGF testing at 19-23 weeks of gestation; therefore, this cannot be recommended as a useful strategy on its own.PMID:37873570 | DOI:10.1111/1471-0528.17684
Source: BJOG : An International Journal of Obstetrics and Gynaecology - Category: OBGYN Authors: Source Type: research